- TRADE NAMES: Castillium; Frisium (Sanofi-Aventis); Mystan; Odipam; Onfi (Lundbeck); Urbanil; Urbanyl
- INDICATIONS: Epilepsy adjunct therapy, psychosis
- CLASS: Anticonvulsant (see also antiepileptic (anti-seizure)), Antiepileptic (anti-seizure), Benzodiazepine
- HALF-LIFE: 36–42 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alcohol, Cannabidiol, Carbamazepine, Cenobamate, Cimetidine, Disulfiram, Fluconazole, Fluvoxamine, Hormonal contraceptives, Levodopa, Moxonidine, Omeprazole, Phenytoin, Rifampin, Sodium Oxybate, Stiripentol, Theophylline, Ticlopidine, Valproic Acid
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of clobazam in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 08/11/2024
